Ketorolac Trometamol Baxter Healthcare

Ketorolac Trometamol, the active ingredient in Ketorolac Trometamol Baxter Healthcare, is a non‑steroidal anti‑inflammatory drug presented as an injectable solution for intramuscular and intravenous administration. It is indicated for the management of moderate to severe acute pain, including postoperative pain, in adult patients requiring short‑term analgesia.

GNH USA supplies Ketorolac Trometamol Baxter Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed across multiple regions globally.

Ketorolac Trometamol is an NSAID that provides analgesia by inhibiting cyclooxygenase enzymes involved in pain pathways.

Moderate to severe acute pain: delivers rapid pain relief for adult patients experiencing intense short‑term pain. Post‑operative pain: reduces discomfort following surgical procedures, facilitating early mobilization and recovery. Short‑term pain management when opioids are unsuitable: offers an alternative analgesic option for patients with contraindications to opioid therapy.

Ketorolac Trometamol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Dizziness - Injection‑site pain or irritation - Gastrointestinal discomfort - Constipation

Serious or Rare Side Effects: - Acute renal impairment or failure - Severe bleeding or gastrointestinal ulceration - Anaphylactic or severe allergic reactions - Cardiovascular events such as myocardial infarction or stroke - Hepatic dysfunction or elevated liver enzymes - Thrombocytopenia or other hematologic abnormalities

When using Ketorolac Trometamol, clinicians should observe several safety measures. - Assess renal function: avoid or adjust use in patients with severe renal impairment. - Monitor bleeding risk: use cautiously with anticoagulants or antiplatelet agents. - Check for NSAID hypersensitivity: discontinue if allergic reactions occur. - Limit duration: prescribe the lowest effective dose for no more than five days. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketorolac Trometamol can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - ACE inhibitors or ARBs: may precipitate acute renal failure.

Moderate Interactions (Monitor Closely): - Diuretics: monitor renal function and electrolytes. - Lithium: ketorolac can raise lithium serum levels. - Methotrexate: reduced clearance may increase toxicity.